← Eichor
Condition: Adults With Overweight Obesity And Type 2 Diabetes Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Adults With Overweight Obesity And Type 2 Diabetes

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Ad
Phase 2 · 2 location(s) · Golo · NCT05844644A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · 173 location(s) · Eli Lilly and Company · NCT07392190A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Phase 3 · 25 location(s) · Pfizer · NCT07595549Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Phase 1 · 2 location(s) · Alveus Therapeutics, Inc. · NCT07399678A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Phase 1/Phase 2 · 5 location(s) · Arrowhead Pharmaceuticals · NCT06700538A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overw
Phase 2 · 42 location(s) · Eli Lilly and Company · NCT07215559A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
Phase 1/Phase 2 · 1 location(s) · Pfizer · NCT06924320Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semagluti
Phase N/A · 2 location(s) · Hospital Italiano de Buenos Aires · NCT07621419A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
Phase 4 · 21 location(s) · Eli Lilly and Company · NCT07438444Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes
Phase 2 · 1 location(s) · Mankind Pharma Limited · NCT07098663Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
NA · 1 location(s) · Kazakh Academy of Nutrition · NCT07728669Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
NA · 1 location(s) · State University of New York at Buffalo · NCT07641361A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Phase 3 · 162 location(s) · Eli Lilly and Company · NCT07321886DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity
NA · 1 location(s) · Adhera Health, Inc. · NCT07638345A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabet
Phase 3 · 12 location(s) · Hoffmann-La Roche · NCT07670416Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
NA · 1 location(s) · GT Metabolic Solutions, Inc. · NCT07317115A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participant
Phase 2 · 40 location(s) · Eli Lilly and Company · NCT07589608A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · 159 location(s) · Eli Lilly and Company · NCT07282600A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Phase 1/Phase 2 · 8 location(s) · Arrowhead Pharmaceuticals · NCT06937203Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide
NA · 2 location(s) · Sheba Medical Center · NCT06497595A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants
Phase 2 · 8 location(s) · Antag Therapeutics · NCT07724340Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Phase 2 · 21 location(s) · Sun Pharmaceutical Industries Limited · NCT07282743A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabete
Phase 4 · 30 location(s) · Eli Lilly and Company · NCT07247084Exercise and Protein Efficiency in T2D
NA · 1 location(s) · University of Illinois at Urbana-Champaign · NCT07477067
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.